{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hawkinsinuria","columns":[{"gene":"","key":"population-a00b9c315698a50f6a34","label":"Hawkinsinuria","mondoId":"MONDO:0007700","onsetQualifier":null,"originColumnKey":"MONDO:0007700/OMIM:140350","originalViews":[{"key":"MONDO:0007700/OMIM:140350","label":"Hawkinsinuria","scopeLabel":"OMIM:140350","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["071c3751203037b03fdc0321529a9b8b9c2418023c53e1ccf6d17ab34ee9edfd","163a841bcd1164ee1275b33b62677fb8a723b6284819f54b537d502463a7037a","1b0f453d7a3e0213816eac867a0c88bb4041660fbc262e339b15deea767b01d4","5ed149a8872ee1721a42dfa4a89e7023fcacc339ab2667438dfc80c2941fae79","6005ab0b91279eae206661123d7fc8e018a87a3d2f5c95c3d175327177102bc4","96fc3d36b0b6bf827da4cbf2b14e373f05b65aa11efbd40dfd4f2a45bd493a9b","ce3205ac30d4cb54e52273fd4c62a333d12f1471ea8120f057a3f8134a90a4fe","d0a3f6df04a80824ee4d903dc13d932b441fcaec63a05c503d36fc70daf5adba","d6e415d8bd47e266dc985d6f0027fc64072d1c0a7b1e9a5529629aad1bd63b0f","e56fb1c8a76ebd320bd10ca546f9a13b6fbfe585712647a81deb1a1ca94aa1f7","e8f0496e95d80b5e048add0985591abc0cafcb38d04f7dafd2fdc414cb59215d"],"recordQualifiers":{},"scopeLabel":"OMIM:140350","sourceIds":["OMIM:140350"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-91dd3fca3f215d1e4dee","label":"Hawkinsinuria","mondoId":"MONDO:0007700","onsetQualifier":null,"originColumnKey":"MONDO:0007700/ORPHA:2118","originalViews":[{"key":"MONDO:0007700/ORPHA:2118","label":"Hawkinsinuria","scopeLabel":"ORPHA:2118","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["35cb89060d6151c53a82cdc015a49c730f08ef9927f0f58b12b93f7094530f31","5a897cff2584d4b491a4a49865edf544682d1b2bab34821578d0593c0ea944cb","71d6cfeb81e2873769e2a460ecb86e09c78e99f4572701bbafda4984d077890a","8078cc00e79c57773c19f31574ea2bebf1504893b20cc748b6346e0275cedbe2","97de9457b941d9a3866234493589d54e20d3d8e2cce252fe8a3800696ac30c78","a13f797b8a6d7f2f5573f85a3cbfc15fc5b05450eac7e4335ce3f4cb7197dac4","b68f404b4943ca1eb95b96a2e14d1c88431ace6bfa15d6e81a81d38c1c03d4bd","b898bd9780605c705045e7f5577b327f64bc230939a3a88762958b112ba6d8d5","d07105432595196c7135d90e89717e35009f89cede0ca846ca7ce007891e4e42"],"recordQualifiers":{},"scopeLabel":"ORPHA:2118","sourceIds":["ORPHA:2118"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-a00b9c315698a50f6a34","population-91dd3fca3f215d1e4dee"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003607","HP:0003161","HP:0010917","HP:6001004","HP:0001508","HP:0002213","HP:0034457"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":10,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":20,"sourceGroups":{"omim":2,"orphanet":9,"published":9}},"features":[{"hpoId":"HP:0003607","label":"4-hydroxyphenylacetic aciduria","primary":true},{"hpoId":"HP:0003161","label":"4-Hydroxyphenylpyruvic aciduria","primary":true},{"hpoId":"HP:0010917","label":"Abnormal circulating tyrosine concentration","primary":true},{"hpoId":"HP:6001004","label":"Elevated urine hydroxyphenyllactic acid level","primary":true},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":true},{"hpoId":"HP:0002213","label":"Fine hair","primary":true},{"hpoId":"HP:0034457","label":"Hawkinsinuria","primary":true},{"hpoId":"HP:0003231","label":"Hypertyrosinemia","primary":false},{"hpoId":"HP:0000821","label":"Hypothyroidism","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0001942","label":"Metabolic acidosis","primary":false},{"hpoId":"HP:0000252","label":"Microcephaly","primary":false},{"hpoId":"HP:0001256","label":"Mild intellectual disability","primary":false},{"hpoId":"HP:0000711","label":"Restlessness","primary":false},{"hpoId":"HP:0008070","label":"Sparse hair","primary":false}],"ledeHtml":"Hawkinsinuria is an inherited disorder, characterized by the inability to break down the amino acid tyrosine. This results in the finding of certain amino acids in the urine, such as hawkinsin. The features of this condition usually appear around the time infants are weaned off breast milk and begin to use formula. The signs and symptoms may include: failure to gain weight and grow at the expected rate (failure to thrive), abnormally high acid levels in the blood (acidosis), and fine or sparse hair. Hawkinsinuria is caused by genetic changes in the HPD gene and is inherited in an autosomal dominant manner.","mondoId":"MONDO:0007700","node":{"canonicalSlug":"hawkinsinuria","comparisons":[{"documentSha256":"a3560edb9d13c76f18270d620438b0deb8a57dfa379bba09118002c6f6f40511","key":"legacy-hawkinsinuria","kind":"legacy","label":"hawkinsinuria","memberIds":["MONDO:0007700"],"mondoId":"MONDO:0007700","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hawkinsinuria.a3560edb9d13c76f18270d620438b0deb8a57dfa379bba09118002c6f6f40511.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hawkinsinuria","originalSourceId":"ORPHA:2118","paragraphs":["Hawkinsinuria is an inherited disorder, characterized by the inability to break down the amino acid tyrosine. This results in the finding of certain amino acids in the urine, such as hawkinsin. The features of this condition usually appear around the time infants are weaned off breast milk and begin to use formula. The signs and symptoms may include: failure to gain weight and grow at the expected rate (failure to thrive), abnormally high acid levels in the blood (acidosis), and fine or sparse hair. Hawkinsinuria is caused by genetic changes in the HPD gene and is inherited in an autosomal dominant manner."],"rawAttribution":"MONDO:0007700","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:05:34Z","upstream":"GARD:0005668","url":"https://rarediseases.info.nih.gov/diseases/5668"},"ownColumnKeys":["population-a00b9c315698a50f6a34","population-91dd3fca3f215d1e4dee"],"publication":"published","relationships":[{"kind":"parent","label":"disorder of tyrosine metabolism","mondoId":"MONDO:0017307","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"071c3751203037b03fdc0321529a9b8b9c2418023c53e1ccf6d17ab34ee9edfd","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:140350","disease_name":"Hawkinsinuria","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0008070","is_excluded":false,"label":"Sparse hair","onset_id":null,"reference":"PMID:11073718","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"163a841bcd1164ee1275b33b62677fb8a723b6284819f54b537d502463a7037a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:140350","disease_name":"Hawkinsinuria","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0034457","is_excluded":false,"label":"Hawkinsinuria","onset_id":null,"reference":"PMID:11073718","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1b0f453d7a3e0213816eac867a0c88bb4041660fbc262e339b15deea767b01d4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:140350","disease_name":"Hawkinsinuria","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0001256","is_excluded":false,"label":"Mild intellectual disability","onset_id":null,"reference":"PMID:11073718","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"35cb89060d6151c53a82cdc015a49c730f08ef9927f0f58b12b93f7094530f31","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2118","disease_name":"Hawkinsinuria","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003161","is_excluded":false,"label":"4-Hydroxyphenylpyruvic aciduria","onset_id":null,"reference":"ORPHA:2118","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5a897cff2584d4b491a4a49865edf544682d1b2bab34821578d0593c0ea944cb","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2118","disease_name":"Hawkinsinuria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:2118","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"5ed149a8872ee1721a42dfa4a89e7023fcacc339ab2667438dfc80c2941fae79","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:140350","disease_name":"Hawkinsinuria","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0003161","is_excluded":false,"label":"4-Hydroxyphenylpyruvic aciduria","onset_id":null,"reference":"PMID:11073718","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"6005ab0b91279eae206661123d7fc8e018a87a3d2f5c95c3d175327177102bc4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:140350","disease_name":"Hawkinsinuria","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0003607","is_excluded":false,"label":"4-hydroxyphenylacetic aciduria","onset_id":null,"reference":"PMID:11073718","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"71d6cfeb81e2873769e2a460ecb86e09c78e99f4572701bbafda4984d077890a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2118","disease_name":"Hawkinsinuria","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0010917","is_excluded":false,"label":"Abnormal circulating tyrosine concentration","onset_id":null,"reference":"ORPHA:2118","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8078cc00e79c57773c19f31574ea2bebf1504893b20cc748b6346e0275cedbe2","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2118","disease_name":"Hawkinsinuria","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002213","is_excluded":false,"label":"Fine hair","onset_id":null,"reference":"ORPHA:2118","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"96fc3d36b0b6bf827da4cbf2b14e373f05b65aa11efbd40dfd4f2a45bd493a9b","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:140350","disease_name":"Hawkinsinuria","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"PMID:11073718","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"97de9457b941d9a3866234493589d54e20d3d8e2cce252fe8a3800696ac30c78","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2118","disease_name":"Hawkinsinuria","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008070","is_excluded":false,"label":"Sparse hair","onset_id":null,"reference":"ORPHA:2118","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a13f797b8a6d7f2f5573f85a3cbfc15fc5b05450eac7e4335ce3f4cb7197dac4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2118","disease_name":"Hawkinsinuria","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003607","is_excluded":false,"label":"4-hydroxyphenylacetic aciduria","onset_id":null,"reference":"ORPHA:2118","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b68f404b4943ca1eb95b96a2e14d1c88431ace6bfa15d6e81a81d38c1c03d4bd","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:2118","disease_name":"Hawkinsinuria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000821","is_excluded":false,"label":"Hypothyroidism","onset_id":null,"reference":"ORPHA:2118","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b898bd9780605c705045e7f5577b327f64bc230939a3a88762958b112ba6d8d5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2118","disease_name":"Hawkinsinuria","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001942","is_excluded":false,"label":"Metabolic acidosis","onset_id":null,"reference":"ORPHA:2118","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"ce3205ac30d4cb54e52273fd4c62a333d12f1471ea8120f057a3f8134a90a4fe","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:140350","disease_name":"Hawkinsinuria","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0000711","is_excluded":false,"label":"Restlessness","onset_id":null,"reference":"PMID:11073718","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"d07105432595196c7135d90e89717e35009f89cede0ca846ca7ce007891e4e42","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:2118","disease_name":"Hawkinsinuria","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:2118","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"d0a3f6df04a80824ee4d903dc13d932b441fcaec63a05c503d36fc70daf5adba","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:140350","disease_name":"Hawkinsinuria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:6001004","is_excluded":false,"label":"Elevated urine hydroxyphenyllactic acid level","onset_id":null,"reference":"OMIM:140350","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"d6e415d8bd47e266dc985d6f0027fc64072d1c0a7b1e9a5529629aad1bd63b0f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:140350","disease_name":"Hawkinsinuria","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0003231","is_excluded":false,"label":"Hypertyrosinemia","onset_id":null,"reference":"PMID:11073718","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e56fb1c8a76ebd320bd10ca546f9a13b6fbfe585712647a81deb1a1ca94aa1f7","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:140350","disease_name":"Hawkinsinuria","evidence":"IEA","frequency_raw":"2/3","hpo_id":"HP:0001942","is_excluded":false,"label":"Metabolic acidosis","onset_id":null,"reference":"OMIM:140350","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"e8f0496e95d80b5e048add0985591abc0cafcb38d04f7dafd2fdc414cb59215d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:140350","disease_name":"Hawkinsinuria","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"PMID:11073718","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/5668\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0007700\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0005668</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Hawkinsinuria is an inherited disorder, characterized by the inability to break down the amino acid tyrosine. This results in the finding of certain amino acids in the urine, such as hawkinsin. The features of this condition usually appear around the time infants are weaned off breast milk and begin to use formula. The signs and symptoms may include: failure to gain weight and grow at the expected rate (failure to thrive), abnormally high acid levels in the blood (acidosis), and fine or sparse hair. Hawkinsinuria is caused by genetic changes in the HPD gene and is inherited in an autosomal dominant manner.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/5668\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"hawkinsinuria","sourceDocuments":[{"name":"GARD: Hawkinsinuria","reviewed":null,"source_release":"2026-10-21T17:05:34Z","url":"https://rarediseases.info.nih.gov/diseases/5668"},{"name":"MONDO: hawkinsinuria","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0007700"}],"sourceNote":"","synonyms":["4-alpha-hydroxyphenylpyruvate hydroxylase deficiency","4-HPPD deficiency","4-hydroxyphenylpyruvic acid dioxygenase deficiency","hawkinsinuria"],"takeawayHtml":"","title":"hawkinsinuria"},"schemaVersion":1}
